| Serial Number | 79344895 |
| Word Mark | MOGANSHAN |
| Filing Date | Tuesday, June 14, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 19, 2024 |
| Registration Number | 7330063 |
| Registration Date | Tuesday, March 19, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 2, 2024 |
| Description of Mark | The mark consists of a circle surrounding stylized clouds, bamboo trees, and mountains. Below the circle are Chinese characters above the wording "MOGANSHAN" in stylized text. |
| NOT AVAILABLE | The non-Latin characters in the mark transliterate to "MO GAN SHAN" and this means "Mount Mogan" in English. |
| Goods and Services | Drugs for medical purposes, namely, adjuvant treatment of myocardial ischemia, shock, hypoxia, and tissue damage; Drugs for medical purposes, namely, antivirals for the treatment of acute zoster, incipient and recurrent genital herpes, and chickenpox; Drugs for medical purposes, namely, antivirals suitable for treating viral pneumonia caused by respiratory syncytial virus, bronchitis, and skin herpes virus infection, in combination with interferon alpha for the treatment of chronic hepatitis C in adults; Drugs for medical purposes, namely, anticancer preparations for choriocarcinoma, malignant mole, acute lymphoblastic leukemia and acute non-lymphoblastic leukemia, and acute stage of chronic granulocytic leukemia; Drugs for medical purposes, namely, antiallergic medicine for the treatment of seasonal rhinitis, perennial allergic rhinitis, allergic conjunctivitis and allergy-induced pruritus and urticaria; Antibiotics; Drugs for medical purposes, namely, adjuvant treatment of acute and chronic hepatitis; Pharmaceutical preparations, namely, adjuvant treatment of myocardial ischemia, shock, hypoxia, and tissue damage; Pharmaceutical preparations, namely, antivirals for the treatment of acute zoster, incipient and recurrent genital herpes, and chickenpox; Pharmaceutical preparations, namely, antivirals suitable for treating viral pneumonia caused by respiratory syncytial virus, bronchitis, and skin herpes virus infection, in combination with interferon alpha for the treatment of chronic hepatitis C in adults; Pharmaceutical preparations, namely, anticancer for choriocarcinoma, malignant mole, acute lymphoblastic leukemia and acute non-lymphoblastic leukemia, and acute stage of chronic granulocytic leukemia; Pharmaceutical preparations, namely, antiallergic medicine for the treatment of seasonal rhinitis, perennial allergic rhinitis, allergic conjunctivitis and allergy-induced pruritus and urticaria; Pharmaceutical preparations, namely, adjuvant treatment of acute and chronic hepatitis; Antivirals suitable for treating viral pneumonia caused by respiratory syncytial virus, bronchitis, and skin herpes virus infection in combination with interferon alpha for the treatment of chronic hepatitis C in adults; Antiallergic medicine for the treatment of seasonal rhinitis, perennial allergic rhinitis, allergic conjunctivitis and allergy-induced pruritus and urticaria; Antivirals for the treatment of acute zoster, incipient and recurrent genital herpes, and chickenpox; Anticancer preparations for choriocarcinoma, malignant mole, acute lymphoblastic leukemia and acute non-lymphoblastic leukemia, and acute stage of chronic granulocytic leukemia |
| NOT AVAILABLE | "MOGANSHAN" AND THE CHINESE CHARACTERS IN THE MARK THAT TRANSLITERATE TO "MO GAN SHAN" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 15, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Zhejiang Zhebei Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Zhejiang Zhebei Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Zhejiang Zhebei Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Friday, March 31, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, July 14, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, July 15, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 19, 2022 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 27, 2023 | ASSIGNED TO EXAMINER |
| Saturday, April 1, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, May 31, 2023 | REFUSAL PROCESSED BY MPU |
| Wednesday, May 31, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, June 18, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, October 26, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 26, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 26, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 10, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, November 10, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, November 10, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, November 10, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, November 16, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, November 16, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 16, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 16, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, November 22, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 13, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, December 13, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 13, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, January 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sunday, January 7, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, December 20, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, December 20, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, January 2, 2024 | NOTIFICATION PROCESSED BY IB |
| Tuesday, March 19, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, June 20, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, March 19, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |